TGFBR1 and neoplasm: We also determined that only a subset of the patient cohorts exhibited a consistent significant reduction in TGFBR1 intensity both within a patient sample in regions near tumor tissue in patients with HCC and between patients when comparing those with HCC to those with only cirrhosis.